We are live on ! Find out more
FPRX

Five Prime Therapeutics, Inc.
FPRX

Delisted

FPRX was delisted on the 15th of April, 2021.

125 hedge funds and large institutions have $664M invested in Five Prime Therapeutics, Inc. in 2020 Q4 according to their latest regulatory filings, with 53 funds opening new positions, 41 increasing their positions, 25 reducing their positions, and 22 closing their positions.

New
Increased
Maintained
Reduced
Closed

433% more capital invested

Capital invested by funds: $125M → $664M (+$540M)

141% more first-time investments, than exits

New positions opened: 53 | Existing positions closed: 22

64% more repeat investments, than reductions

Existing positions increased: 41 | Existing positions reduced: 25

33% more funds holding

Funds holding: 94125 (+31)

3% more call options, than puts

Call options by funds: $4.63M | Put options by funds: $4.51M

Holders
125
Holders Change
+31
Holders Change %
+32.98%
% of All Funds
2.21%
Holding in Top 10
1
Holding in Top 10 Change
+1
Holding in Top 10 Change %
% of All Funds
0.02%
New
53
Increased
41
Reduced
25
Closed
22
Calls
$4.63M
Puts
$4.51M
Net Calls
+$122K
Net Calls Change
+$42K
Name Holding Trade Value Shares
Change
Change in
Stake
Squarepoint
51
Squarepoint
New York
$1.32M +$1.28K +102 +0.1%
AC
52
Athanor Capital
New York
$1.31M +$541K +43,145 +127%
QI
53
QS Investors
New York
$1.14M +$249K +19,900 +43%
AllianceBernstein
54
AllianceBernstein
Tennessee
$1.12M -$117K -9,300 -12%
AQR Capital Management
55
AQR Capital Management
Connecticut
$1.04M -$2.01M -160,485 -72%
Jane Street
56
Jane Street
New York
$1.03M +$486K +38,813 +178%
California Public Employees Retirement System
57
California Public Employees Retirement System
California
$1.02M +$74.2K +5,921 +11%
Man Group
58
Man Group
United Kingdom
$1.02M -$1.42M -113,407 -65%
HIM
59
Hillsdale Investment Management
Ontario, Canada
$963K -$1.29M -103,000 -65%
RhumbLine Advisers
60
RhumbLine Advisers
Massachusetts
$924K +$123K +9,853 +22%
SSA
61
Schonfeld Strategic Advisors
New York
$919K +$677K +54,011 New
ACM
62
Atika Capital Management
New York
$872K +$642K +51,273 New
California State Teachers Retirement System (CalSTRS)
63
California State Teachers Retirement System (CalSTRS)
California
$805K +$87.3K +6,965 +17%
TD Asset Management
64
TD Asset Management
Ontario, Canada
$802K +$591K +47,157 New
Morgan Stanley
65
Morgan Stanley
New York
$707K +$337K +26,876 +183%
Marshall Wace
66
Marshall Wace
United Kingdom
$592K +$436K +34,811 New
SEI Investments
67
SEI Investments
Pennsylvania
$576K +$424K +33,856 New
TRSOTSOK
68
Teachers Retirement System of the State of Kentucky
Kentucky
$563K +$415K +33,118 New
Jennison Associates
69
Jennison Associates
New York
$552K +$406K +32,438 New
FSA
70
Franklin Street Advisors
North Carolina
$510K -$251K -20,000 -40%
New York State Common Retirement Fund
71
New York State Common Retirement Fund
New York
$502K +$209K +16,700 +130%
Deutsche Bank
72
Deutsche Bank
Germany
$501K +$198K +15,775 +116%
TI
73
Trexquant Investment
Connecticut
$414K +$305K +24,360 New
CCIA
74
Campbell & Co Investment Adviser
Maryland
$361K +$266K +21,200 New
CS
75
Credit Suisse
Switzerland
$357K +$263K +20,966 New

FPRX Hedge Fund Activity: Q4 2020 in Review

125 of the 5,651 institutional investors tracked by Wall St. Rank reported a position in Five Prime Therapeutics, Inc. (FPRX) for Q4 2020, worth a combined $664M — up 433% from $125M a quarter earlier.

Buyers outnumbered sellers: 53 funds opened new FPRX positions and 22 closed out — a net gain of 31 holders — while 41 added to existing stakes and 25 trimmed.

The largest buyer was RA Capital Management, opening a new position worth an estimated $53.7M. The largest seller was BVF Inc, cutting an estimated $87.3M.

  • 125 institutional investors held Five Prime Therapeutics, Inc. (FPRX) as of Q4 2020, up from 94 in Q3 2020.
  • Funds reported $664M of Five Prime Therapeutics, Inc. stock for Q4 2020, up 433% quarter-over-quarter.
  • 53 funds opened new Five Prime Therapeutics, Inc. positions in Q4 2020 and 22 closed out, a net change of +31 holders.
  • The largest Five Prime Therapeutics, Inc. buyer in Q4 2020 was RA Capital Management, an estimated $53.7M added.
  • The largest Five Prime Therapeutics, Inc. seller in Q4 2020 was BVF Inc, an estimated $87.3M sold.

Based on aggregated 13F filings for Q4 2020.